Dietary Phytochemicals in Cancer Signalling Pathways: Role of miRNA Targeting

Ambreen Shoaib1, Mohammad Tabish2, Shafat Ali3

  • 1Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.

Insights

Dietary phytochemicals regulate microRNAs (miRNAs) to combat cancer. These natural compounds offer a safe, cost-effective approach to cancer treatment by modulating gene expression and inhibiting tumor progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Nutritional Science

Background:

  • Cancer is a complex disease driven by genetic mutations and uncontrolled cell division, often leading to recurrence or resistance with conventional therapies.
  • MicroRNAs (miRNAs) play a crucial role in cancer development and progression by regulating genes involved in cell proliferation, growth, differentiation, and apoptosis.
  • Current cancer treatments like chemotherapy face limitations due to recurrence and resistance, highlighting the need for novel therapeutic strategies.

Purpose of the Study:

  • To explore the potential of dietary phytochemicals as anticancer agents by examining their role in regulating microRNAs (miRNAs).
  • To identify specific phytochemicals and their mechanisms of action in modulating cancer-related signaling pathways via miRNA regulation.
  • To establish phytochemical-miRNA interactions as a safe and effective therapeutic avenue for cancer treatment.

Main Methods:

  • Literature review of studies investigating the effects of dietary phytochemicals on miRNA expression in various cancer types.
  • Analysis of specific phytochemicals, including curcumin, resveratrol, and epigallocatechin-3-gallate, and their impact on cancer signaling pathways.
  • Identification of targeted miRNAs and their associated cellular pathways modulated by phytochemicals.

Main Results:

  • Several dietary phytochemicals, such as curcumin, resveratrol, and epigallocatechin-3-gallate, demonstrate significant regulatory effects on miRNA expression.
  • These phytochemicals modulate key cancer signaling pathways, including SHH, Notch, TGFβ1/SMAD, Wnt/β-catenin, and JAK2/STAT3, thereby inhibiting cancer progression.
  • Phytochemicals can upregulate or downregulate specific miRNAs, offering a targeted approach to cancer therapy.

Conclusions:

  • Dietary phytochemicals represent a promising class of compounds for cancer treatment due to their ability to regulate miRNAs.
  • Targeting miRNAs with specific phytochemicals provides a safe, cost-effective, and potentially more effective strategy compared to conventional therapies.
  • Further research into phytochemical-miRNA interactions can lead to novel therapeutic interventions for various cancers.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.8K